KemPharm Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS™ - BioSpace

Submitted by Anonymous (not verified) on Thu, 04/08/2021 - 20:25

KemPharm Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS™  BioSpace